Abstract
Summary
Eight derivatives of 3-acetyl strophanthidin have been synthesized and studied pharmacologically in cats. None of the new compounds is as active as 3-acetyl strophanthidin, although 2 of them approach the parent aglycone, strophanthidin, in potency. The significance of certain structural changes against cardiac activity has been pointed out.
Get full access to this article
View all access options for this article.